You keep putting waaaaaay too much emphasis on MITIGATE. There is only upside to MITIGATE, not downside....... this trial is not designed to determine event line separation in CVD patients. It's designed to see if V can also prevent or reduce the risk of complications from viral respiratory illnesses in older adults with heart disease. That's it...... PERIOD.